代谢异常相关的早期感觉缺陷及其与周围神经病变发展的关系
本研究纳入225例无周围神经病变的个体(117例无2型糖尿病,108例有2型糖尿病),采用标准化定量感觉测试识别早期周围感觉功能障碍(EPSD),并随访196例平均2.64年。结果显示,无糖尿病者中胰岛素抵抗指标与EPSD独立相关,糖尿病者中代谢综合征和皮肤晚期糖基化终末产物是独立预测因子;糖尿病、EPSD、较高胰岛素抵抗和AGEs预测周围神经病变发生,感觉丧失表型关联最强。
要点
- 无2型糖尿病者中,胰岛素抵抗指标与早期感觉功能障碍独立相关。
- 2型糖尿病者中,代谢综合征和皮肤AGEs是早期感觉功能障碍的独立预测因子。
- 糖尿病、EPSD、较高胰岛素抵抗和AGEs预测周围神经病变发生,感觉丧失表型关联最强。
核心结论
- 首次证明标准化QST方法可用于识别有无2型糖尿病个体的早期感觉缺陷,这些缺陷与胰岛素抵抗标志物、代谢综合征和较高AGEs所标志的代谢异常状态相关,进而影响周围神经病变发展。
研究设计与样本
- 分析225例经临床和电生理标准判定无周围神经病变的个体(117例无2型糖尿病,108例有2型糖尿病),基于标准化QST方案比较健康者与EPSD者,并对196例平均随访2.64年观察周围神经病变发生。
主要发现
- 无2型糖尿病者中,除男性、身高、较高脂肪量和较低瘦体重外,仅较高胰岛素抵抗(HOMA-IR OR 1.70,P=0.009;McAuley指数 OR 0.62,P=0.008)与EPSD独立相关。
- 2型糖尿病者中,代谢综合征(OR 18.32,P<0.001)和皮肤AGEs(OR 5.66,P=0.003)是EPSD的独立预测因子。
- 纵向分析中,2型糖尿病(HR 3.32 vs 无糖尿病,P<0.001)、EPSD(校正糖尿病和性别后 HR 1.88 vs 健康,P=0.049)、较高胰岛素抵抗和AGEs预测周围神经病变发生。
- 3种EPSD相关感觉表型中,感觉丧失与周围神经病变发展关联最强(校正后 HR 4.35,P=0.011)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To investigate the association of early peripheral sensory dysfunction (EPSD) identified through quantitative sensory testing (QST) with factors related to a dysmetabolic status in individuals with and without type 2 diabetes (T2DM) without peripheral neuropathy (PN), and the impact of those factors on PN development. METHODS: A total of 225 individuals (117 and 108 without and with T2DM, respectively) without PN based on clinical and electrophysiological criteria were analyzed. Comparative analysis was conducted between those identified as "healthy" and those with EPSD based on a standardized QST protocol. A total of 196 were followed-up over a mean of 2.64 years for PN occurrence. RESULTS: Among those without T2DM, apart from male sex, height, and higher fat and lower lean mass, only higher insulin resistance (IR; homeostatic model assessment for IR: odds ratio [OR], 1.70; P = .009; McAuley index OR, 0.62, P = .008), was independently associated with EPSD. In T2DM, metabolic syndrome (OR, 18.32; P < .001) and skin advanced glycation end-products (AGEs; OR, 5.66; P = .003) were independent predictors of EPSD. In longitudinal analysis, T2DM (hazard ratio [HR], 3.32 vs no diabetes mellitus; P < .001), EPSD (adjusted HR, 1.88 vs healthy; P = .049 adjusted for diabetes mellitus and sex), higher IR and AGEs predicted PN development. Among the 3 EPSD-associated sensory phenotypes, "sensory loss" was most strongly associated with PN development (adjusted HR, 4.35; P = .011). CONCLUSION: We demonstrate for the first time the utility of a standardized QST-based approach in identifying early sensory deficits in individuals with and without T2DM. These are associated with a dysmetabolic status signified by IR markers, metabolic syndrome, and higher AGEs, which in turn are shown to influence PN development.
引用
- Tsilingiris D, Schimpfle L, von Rauchhaupt E, et al. Dysmetabolism-related Early Sensory Deficits and Their Relationship With Peripheral Neuropathy Development. J Clin Endocrinol Metab. 2023. PMID: 37139855. doi:10.1210/clinem/dgad248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。